Article Details
Retrieved on: 2025-06-25 12:51:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibody targeting ACTRII, which is being developed by Eli Lilly following its acquisition of Versanis Bio in 2023. Combination of SPCD ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here